Logo image of SEDG

SOLAREDGE TECHNOLOGIES INC (SEDG) Stock Fundamental Analysis

NASDAQ:SEDG - US83417M1045 - Common Stock

31.915 USD
-1.91 (-5.63%)
Last: 9/2/2025, 1:47:36 PM
Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to SEDG. SEDG was compared to 112 industry peers in the Semiconductors & Semiconductor Equipment industry. SEDG has a bad profitability rating. Also its financial health evaluation is rather negative. SEDG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SEDG has reported negative net income.
In the past year SEDG has reported a negative cash flow from operations.
Of the past 5 years SEDG 4 years were profitable.
The reported operating cash flow has been mixed in the past 5 years: SEDG reported negative operating cash flow in multiple years.
SEDG Yearly Net Income VS EBIT VS OCF VS FCFSEDG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500M -1B -1.5B

1.2 Ratios

With a Return On Assets value of -69.93%, SEDG is not doing good in the industry: 91.07% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -339.33%, SEDG is doing worse than 91.96% of the companies in the same industry.
Industry RankSector Rank
ROA -69.93%
ROE -339.33%
ROIC N/A
ROA(3y)-21.91%
ROA(5y)-10.83%
ROE(3y)-89.6%
ROE(5y)-48.59%
ROIC(3y)N/A
ROIC(5y)N/A
SEDG Yearly ROA, ROE, ROICSEDG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SEDG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEDG Yearly Profit, Operating, Gross MarginsSEDG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

1

2. Health

2.1 Basic Checks

SEDG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SEDG has more shares outstanding
Compared to 5 years ago, SEDG has more shares outstanding
The debt/assets ratio for SEDG is higher compared to a year ago.
SEDG Yearly Shares OutstandingSEDG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
SEDG Yearly Total Debt VS Total AssetsSEDG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

Based on the Altman-Z score of -0.93, we must say that SEDG is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.93, SEDG is not doing good in the industry: 75.00% of the companies in the same industry are doing better.
SEDG has a Debt/Equity ratio of 0.72. This is a neutral value indicating SEDG is somewhat dependend on debt financing.
SEDG has a worse Debt to Equity ratio (0.72) than 77.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z -0.93
ROIC/WACCN/A
WACC11.13%
SEDG Yearly LT Debt VS Equity VS FCFSEDG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

SEDG has a Current Ratio of 1.94. This is a normal value and indicates that SEDG is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.94, SEDG is not doing good in the industry: 73.21% of the companies in the same industry are doing better.
A Quick Ratio of 1.42 indicates that SEDG should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.42, SEDG is doing worse than 75.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.42
SEDG Yearly Current Assets VS Current LiabilitesSEDG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

The earnings per share for SEDG have decreased strongly by -303.10% in the last year.
Looking at the last year, SEDG shows a very negative growth in Revenue. The Revenue has decreased by -37.76% in the last year.
SEDG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.76% yearly.
EPS 1Y (TTM)-303.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.75%
Revenue 1Y (TTM)-37.76%
Revenue growth 3Y-22.86%
Revenue growth 5Y-8.76%
Sales Q2Q%9.05%

3.2 Future

Based on estimates for the next years, SEDG will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.52% on average per year.
SEDG is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.68% yearly.
EPS Next Y87.06%
EPS Next 2Y41.47%
EPS Next 3Y27.49%
EPS Next 5Y17.52%
Revenue Next Year28.11%
Revenue Next 2Y24.43%
Revenue Next 3Y18.81%
Revenue Next 5Y14.68%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SEDG Yearly Revenue VS EstimatesSEDG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
SEDG Yearly EPS VS EstimatesSEDG Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5 -10 -15 -20

1

4. Valuation

4.1 Price/Earnings Ratio

SEDG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 1086.43 indicates a quite expensive valuation of SEDG.
Based on the Price/Forward Earnings ratio, SEDG is valued a bit more expensive than 66.96% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.76. SEDG is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 1086.43
SEDG Price Earnings VS Forward Price EarningsSEDG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800 1K

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEDG Per share dataSEDG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
SEDG's earnings are expected to grow with 27.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.47%
EPS Next 3Y27.49%

0

5. Dividend

5.1 Amount

SEDG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SOLAREDGE TECHNOLOGIES INC

NASDAQ:SEDG (9/2/2025, 1:47:36 PM)

31.915

-1.91 (-5.63%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-04 2025-11-04/amc
Inst Owners99.54%
Inst Owner Change-1.79%
Ins Owners1.21%
Ins Owner Change0.94%
Market Cap1.89B
Analysts50
Price Target20.15 (-36.86%)
Short Float %21.66%
Short Ratio2.5
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.58%
Min EPS beat(2)3.68%
Max EPS beat(2)7.47%
EPS beat(4)2
Avg EPS beat(4)-230.09%
Min EPS beat(4)-822.2%
Max EPS beat(4)7.47%
EPS beat(8)3
Avg EPS beat(8)-134.78%
EPS beat(12)6
Avg EPS beat(12)-82.23%
EPS beat(16)7
Avg EPS beat(16)-65.01%
Revenue beat(2)2
Avg Revenue beat(2)4.62%
Min Revenue beat(2)3.59%
Max Revenue beat(2)5.66%
Revenue beat(4)3
Avg Revenue beat(4)1.48%
Min Revenue beat(4)-5.05%
Max Revenue beat(4)5.66%
Revenue beat(8)4
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.66%
Revenue beat(16)5
Avg Revenue beat(16)-0.82%
PT rev (1m)-1.48%
PT rev (3m)10.43%
EPS NQ rev (1m)35.15%
EPS NQ rev (3m)12.56%
EPS NY rev (1m)12.37%
EPS NY rev (3m)13.58%
Revenue NQ rev (1m)8.59%
Revenue NQ rev (3m)5.94%
Revenue NY rev (1m)6.93%
Revenue NY rev (3m)7.22%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 1086.43
P/S 2.01
P/FCF N/A
P/OCF N/A
P/B 3.69
P/tB 4.18
EV/EBITDA N/A
EPS(TTM)-20.8
EYN/A
EPS(NY)0.03
Fwd EY0.09%
FCF(TTM)-1.63
FCFYN/A
OCF(TTM)-0.43
OCFYN/A
SpS15.84
BVpS8.64
TBVpS7.64
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -69.93%
ROE -339.33%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-21.91%
ROA(5y)-10.83%
ROE(3y)-89.6%
ROE(5y)-48.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 155.48%
Cap/Sales 7.55%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.42
Altman-Z -0.93
F-Score3
WACC11.13%
ROIC/WACCN/A
Cap/Depr(3y)284.9%
Cap/Depr(5y)325.84%
Cap/Sales(3y)8.21%
Cap/Sales(5y)8.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-303.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%54.75%
EPS Next Y87.06%
EPS Next 2Y41.47%
EPS Next 3Y27.49%
EPS Next 5Y17.52%
Revenue 1Y (TTM)-37.76%
Revenue growth 3Y-22.86%
Revenue growth 5Y-8.76%
Sales Q2Q%9.05%
Revenue Next Year28.11%
Revenue Next 2Y24.43%
Revenue Next 3Y18.81%
Revenue Next 5Y14.68%
EBIT growth 1Y-164.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year81.92%
EBIT Next 3Y28.54%
EBIT Next 5Y18.5%
FCF growth 1Y28.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-170.65%
OCF growth 3YN/A
OCF growth 5YN/A